Total raised
—
Stage
Pre-Funding
Founded
2018
Headcount
6
HQ
Nitzan
Sector
Health Tech & Life Sciences
About
Hila Pharma is developing products for molecular imaging that will allow precise diagnoses and improved therapy planning. Its main profits come from the field of nuclear medicine, for which the company trades a broad range of products, aimed at both diagnostic and therapeutic purposes.
Hila Pharma is capable of supplying any type of the SPECT range of diagnostic products, PET diagnostic products, MRI contrast agents, and several nuclear therapeutic materials, such as LU-177.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Hila Pharma's primary focus in product development?
- Hila Pharma is developing products for molecular imaging to enable precise diagnoses and improve therapy planning.
- What is the primary source of Hila Pharma's profits?
- Hila Pharma's main profits come from the field of nuclear medicine, where it trades a broad range of diagnostic and therapeutic products.
- What types of diagnostic and therapeutic products does Hila Pharma supply?
- Hila Pharma supplies SPECT range diagnostic products, PET diagnostic products, MRI contrast agents, and nuclear therapeutic materials like LU-177.
- When was Hila Pharma founded?
- Hila Pharma was founded in November 2018.
- Where is Hila Pharma's headquarters located?
- Hila Pharma's headquarters is in Nitzan, South District, Israel, at HaGefen Street 26.
- What is Hila Pharma's current funding stage?
- Hila Pharma is currently in the Pre-Funding stage.
- How many employees does Hila Pharma have?
- Hila Pharma has between 1 and 10 employees.
- Who are the founders of Hila Pharma?
- The founders of Hila Pharma are Tsvi Dahan and Meir Dahan.
- What is the 'ProtectAir' product associated with Hila Pharma?
- ProtectAir is a product developed by Hila Pharma, which was reported in September 2020 to kill over 99% of airborne viruses.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyDrugs Discovery & DevelopmentIndustrial TechnologiesMaterial Innovations & Applications
Technologies
Materials & SubstancesSimulation & Imaging
Target customers
EducationIndustrial ManufacturingProcess IndustriesCoatingsHealthcare & Life SciencesHealthcareProvidersGovernment & CityTransportation & Logistics
Business model
B2GB2CB2B
Tags
disinfectantsdiagnosticsmedical-devicesradiopharmaceuticalshealthcare-providersbacteriaskin-caremedical-technologiesclean-airgovernmentpublic-transportationsurface-and-coatingsschoolstreatmentsfiltration-and-purificationcancerpeptideshospitals